Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Opio
    Member
    • Oct 2017
    • 10

    #1

    Methylation, statistics and methylated regions

    Hi,

    I'm posting after a look on the forum, and as a newbie, I admit that I didn't find the information I was looking for.

    I'm now with already trimmed, aligned, sorted, bam file of WGBS (whole genome bi sulfite).
    My mission is to get out of it statistics about that file as a preliminary job.

    I looked on different softwares that could help me with, I found MethylExtract. I now also have VCF differenciating SNP and 5mC (but interestingly, I don't think I have non-methylated Cytosines).

    My goal is to be able to characterize CpG Islands (where/how many), characterize CpG, telling if some regions are more methylated than others..

    I think I have a good start with that VCF out of MethylExtract, but so far I can only see it on IGV.

    * Is there a different software I can use to help me in characterizing all that, or should I do it with a script?
    * Is my VCF sufficient at all ?
    * What are the software post-bismark (used later in your pipeline than bismark) that you would use for that purpose?
    * How can I have an estimation of Methylated CpG and non Methylated CpG (taken in account that some regions are hard to sequence, that doesn't correlate with the fact they are devoted or not of methylation)


    * is there a way to annotate (like we could do with whole-exome sequencing) with genes?

    Last question, one of my file is a woman (no Y sequences aligned), but I'm surprised to see that on that chromosome I can't find > 50% of Cytosines methylated in my bam file (seen on IGV) or a eye-judged higher methylation rate in that chromosome. Is that normal?

    Thank you for all your answers,

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...